Nova Peptide
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Nova Peptide between 5 Jun 2026 and 10 Jul 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Nova Peptide
Retatrutide
Tested 4 Samples
Last test 10 Jul 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Nova Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
10 Jul 2026
First
5 Jun 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 10 Jul 2026 | View | 20mg | 21.1mg | +5.5% | 99.80% | RTL-20250602-01 | Silver label / Silver crimp / Black cap | Lab G | Public | |
| 24 Jun 2026 | View | 20mg | 18.7mg | -6.5% | 99.90% | 05012026 | White label / Silver crimp / Blue cap | Lab E | Public | |
| 8 Jun 2026 | View | 15mg | 15.2mg | +1.3% | 99.60% | (no batch ID) | No label / Silver crimp / Clear cap | Lab G | Public | |
| 5 Jun 2026 | View | 10mg | 10.1mg | +1.0% | 99.90% | 2605-048 | No label / Silver crimp / Clear Blue cap | Lab E | Public | |